Chromogenic anti-Xa test: the ratio between heparin activity units and concentration of apixaban and rivaroxaban
Introduction. The direct oral anticoagulants (DOC) therapy does not require alaboratory control; however, it may be required to determine the anticoagulationlevel to choose a treatment strategy if alarge bleeding is developing or emergency surgery is needed.The objective of this experimental study w...
Saved in:
Main Authors: | E. V. Titaeva (Author), A. B. Dobrovolsky (Author) |
---|---|
Format: | Book |
Published: |
«REMEDIUM GROUP» Ltd.,
2020-12-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Potency evaluation of unfractionated heparins commercialized in Brazil through anti-factor Xa and anti-factor IIa chromogenic tests and coagulation assay
by: Renata Jurema Medeiros, et al.
Published: (2023) -
Anti-Xa Inhibitor-Induced Hemorrhagic Pruritic Rash: A Case Report on Possible Cross-Reactivity Between Apixaban and Rivaroxaban
by: Anis TR, et al.
Published: (2021) -
Effect of famotidine on the pharmacokinetics of apixaban, an oral direct factor Xa inhibitor
by: Upreti VV, et al.
Published: (2013) -
Thrombin and Factor Xa Hydrolysis of Chromogenic Substrates in the Presence of Sulfated Derivatives of Galactomannan and Galactoglucomannan Natural Gels
by: Natalia N. Drozd, et al.
Published: (2022) -
International Normalized Ratio as a Screening Test for Assessment of Anticoagulant Activity for Patients Treated With Rivaroxaban or Apixaban: A Pilot Study
by: Fanny Ofek, et al.
Published: (2019)